1246348-09-3

Basic information

• Product Name: cyclohexyl-{3-[3-((S)-3-phenyl-piperidin-1-yl)-propyl]-1H-pyrazolo[4,3-c]pyridin-4-yl}-amine
• Synonyms: cyclohexyl-{3-[3-((S)-3-phenyl-piperidin-1-yl)-propyl]-1H-pyrazolo[4,3-c]pyridin-4-yl}-amine
• CAS NO: 1246348-09-3
• Molecular Weight: 417.597
• Mol File: 1246348-09-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: cyclohexyl-{3-[3-((S)-3-phenyl-piperidin-1-yl)-propyl]-1H-pyrazolo[4,3-c]pyridin-4-yl}-amine(CAS DataBase Reference)
• NIST Chemistry Reference: cyclohexyl-{3-[3-((S)-3-phenyl-piperidin-1-yl)-propyl]-1H-pyrazolo[4,3-c]pyridin-4-yl}-amine(1246348-09-3)
• EPA Substance Registry System: cyclohexyl-{3-[3-((S)-3-phenyl-piperidin-1-yl)-propyl]-1H-pyrazolo[4,3-c]pyridin-4-yl}-amine(1246348-09-3)

Safety Data

• Hazardous Substances Data: 1246348-09-3(Hazardous Substances Data)

Upstream product

• 134031-24-6 2,4-dichloro-3-pyridine Carboxaldehyde 
• 1246350-04-8 (E)-3-[4-Cyclohexylamino-1-(4-methoxy-benzyl)-1H-pyrazolo[4,3-c]pyridin-3-yl]-acrylic acid methyl ester 
• 1246350-05-9 3-[4-cyclohexylamino-1-(4-methoxy-benzyl)-1H-pyrazolo[4,3-c]pyridin-3-yl]-propionic acid methyl ester 
• 1246349-98-3 cyclohexyl-[3-iodo-1-(4-methoxy-benzyl)-1H-pyrazolo[4,3-c]pyridin-4-yl]-amine 
• 1246349-97-2 4-chloro-3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[4,3-c]pyridine 
• 1186647-69-7 4-chloro-3-iodo-1H-pyrazolo[4,3-c]pyridine 
• 871836-51-0 4-chloro-1H-pyrazolo [4,3-c]pyridine 
• 26452-80-2 2,4-dichloropyridine 
• 1246348-25-3 3-(4-cyclohexylamino-1H-pyrazolo[4,3-c]pyridin-3-yl)-propan-1-ol 
• 59349-71-2 (S)-3-phenylpiperidine hydrochloride 

Relevant articles and documents

COMPOUNDS

A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein R1 is selected from: aryl; heteroaryl; -NHR3; fused aryl-C4-7-heterocycloalkyI; -CONR4R5; -NHCOR6; -C3-7-cycloalkyl; -O-C3-7-cycloalkyl; -NR3R6; and optionally substituted -C1-6 alkyl; wherein said aryl, heteroaryl, fused aryl-C4-7-heterocycloalkyl and C4-7-heterocycloalkyl are each optionally substituted; R2 is selected from hydrogen, aryl, C1-6-alkyl, C2-6-alkenyl, C3-7-cycloalkyl, heteroaryl, C4-7 heterocycloalkyl and halogen, wherein said C1-6-alkyl, C2-6-alkenyl, aryl, heteroaryl and C4-7-heterocycloalkyl are each optionally substituted. Further aspects relate to pharmaceutical compositions, therapeutic uses and process for preparing compounds of formula (I).